Banks paid, staples scrutinized
Earnings did the work again. Canadian Imperial Bank of Commerce (CIBC) traded higher after FQ3 double-digit profit growth. Investors showed up looking for cracks from credit normalization and deposit competition and didn’t find them. In banks, the bar isn’t flashy growth—it’s proving the engine holds up when rates are restrictive and funding gets noisy.
Staples didn’t get the same grace. Hormel Foods (HRL) fell on a familiar mix: a Q3 sales miss alongside a raised adjusted EPS outlook. The outlook helps on cost discipline and mix, but it keeps the spotlight where it’s been: volumes, elasticity, and whether consumers are still trading down. Defensive doesn’t mean exempt. You still need a credible top-line story that isn’t just price.
Growth leadership
Software got its leader moment. Salesforce (CRM) moved higher on an earnings beat, then extended gains as analysts lifted price targets. That follow-through matters because it keeps the post-print bid alive and gives portfolio managers a liquid, consensus way to add risk without making a heroic macro call. CRM holding up also supports the broader read: enterprise spend may be choppy, but it isn’t falling off a cliff.
Biotech offered a cleaner “finance it while the window’s open” setup. Moderna (MRNA) traded up even as it announced a $2 billion note offering, with proceeds slated for cancer vaccine investment and debt repayment. Financing usually hurts when the market suspects need. This time it was treated as opportunistic—fund long-cycle R&D and tidy the balance sheet without spooking holders. The terms will matter, but the first reaction said investors weren’t offended.
Deals, capex, metals
Corporate headlines were mostly about pruning and spending—two signals that management teams are still planning beyond the next quarter.
Unilever plans to sell Colman’s ahead of a merger inside its food business. It’s portfolio cleanup. The asset isn’t the story; simplification is, especially in slow categories where complexity becomes a quiet drag.
Kioxia and Sandisk said they’ll jointly invest over $31 billion in Japan. It’s a big commitment on a long runway. Memory capex always carries the oversupply fear, but the messaging leaned toward demand confidence tied to data growth and AI workloads. The market doesn’t need perfect timing; it wants to see the strategic build stays intact.
Commodities-linked equities also kept strength. A gauge of South African precious-metal miners was on pace for its largest monthly gain in at least 20 years, riding a rebound in gold and platinum. That’s not a one-session pop—it’s positioning and operating leverage finally lining up. Miners are trading like a hybrid: commodity beta with a built-in macro hedge and enough torque to make risk managers nervous in both directions.
Jackson Hole stayed in the background—first symposium with Chair Kevin Warsh, with Kansas City Fed President Jeff Schmid participating. With no major data driving the tape, micro catalysts ran the session. Markets mostly waited for tone, reaction function, and whether they get explicit permission to extend risk.
What mattered
- CIBC showed durability; banks will take “steady” over “surprise.”
- HRL reminded the market staples still get graded on volume.
- CRM had the cleanest momentum: beat plus upgrades brought real flows.
- MRNA funded into strength; the market let it happen.
Today was a reminder that in a quiet macro tape, the winners are the names that can prove they’re still in control of their own numbers.